| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.263 | 31.941 | 413.657 | 2.098.820 | 1.608.652 | 1.079.024 |
| Total Income - EUR | - | - | - | - | 8.263 | 67.262 | 415.298 | 2.124.044 | 1.611.942 | 1.079.049 |
| Total Expenses - EUR | - | - | - | - | 13.323 | 43.182 | 115.128 | 524.841 | 926.361 | 779.485 |
| Gross Profit/Loss - EUR | - | - | - | - | -5.060 | 24.080 | 300.170 | 1.599.203 | 685.582 | 299.563 |
| Net Profit/Loss - EUR | - | - | - | - | -5.142 | 23.220 | 296.116 | 1.414.771 | 581.772 | 247.841 |
| Employees | - | - | - | - | 2 | 0 | 1 | 4 | 9 | 3 |
Check the financial reports for the company - Neuro Enhancement S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 19.661 | 12.957 | 89.639 | 268.394 | 380.423 | 281.442 |
| Current Assets | - | - | - | - | 10.088 | 12.653 | 232.570 | 1.283.919 | 355.939 | 423.359 |
| Inventories | - | - | - | - | 1.689 | 937 | 4.840 | 34.038 | 34.192 | 63.138 |
| Receivables | - | - | - | - | 0 | 1.006 | 38.603 | 1.085.045 | 68.877 | 329.705 |
| Cash | - | - | - | - | 8.399 | 10.710 | 189.128 | 164.837 | 252.871 | 30.516 |
| Shareholders Funds | - | - | - | - | -5.100 | 18.216 | 296.165 | 1.414.819 | 581.820 | 247.889 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 8.072 | 7.393 | 26.150 | 177.268 | 179.252 | 461.907 |
| Income in Advance | - | - | - | - | 26.777 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Neuro Enhancement S.r.l.